Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment

Neuroscience Letters

Volumn 165, Issue 1-2, 1994, Pages 41-44

  Youngren, Kenneth D ^a,b   Moghaddam, Bita ^a,b   Bunney, Benjamin S ^a,b   Roth, Robert H ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Clozapine; Dopamine; Microdialysis; Nucleus accumbens; Prefrontal cortex; Striatum

Indexed keywords

CLOZAPINE; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANIMAL; CLOZAPINE; DOPAMINE; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; NEOSTRIATUM; NERVE ENDINGS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027972670     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(94)90704-8     Document Type: Article

References (21)

1. Das klinische Wirkungsbild von Clozapine (Untersuchung mit dem AMP-System)
2. Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo brain microdialysis: further evidence for depolarization block
3. Effects of acute and chronic clozapine on dopaminergic function in medial prefrontal cortex of awake, freely moving rats
4. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons
5. Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis
6. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis
7. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens
8. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats
9. Clozaril Collaborative Study Group, Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine
10. Anesthetic influences on the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons
11. Differential changes in dopamine and serotonin receptors induced by clozapine and haloperidol
12. Ionic composition of microdialysis perfusing solution alters the basal release and pharmacological responsiveness of striatal dopamine
13. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study
14. Stress and the mesocorticolibic dopamine systems
15. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat
16. Implications of normal brain development for the pathogenesis of schizophrenia
17. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence
18. The significance of extracellular calcium for the release of dopamine, acetylcholine, and amino acids in conscious rats, evaluated by brain microdialysis
19. Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens